Skip to main content
. 2019 Feb 28;10:364. doi: 10.3389/fmicb.2019.00364

Table 1.

Characteristics of isolates obtained from Lake Água Preta.

Isolate 16S rRNA gene Affiliation Resistance (and intermediate) phenotype Resistance genotype Integrase genes
APC43A Escherichia coli NBRC 102203 (99%) AML, AMC, AMP, CEF, CAZ, CTX, FEP, ATM, CIP, NAL (KAN)b blaCTX–M–15a
APC25 Acinetobacter baumannii DSM 30007 (97%) AML, AMC, AMP, CEF, CAZ, CTX, ATM, CIP, NAL (KAN) a
APC4 Citrobacter werkmanii CDC 0876-58 (99%) AML, AMC, AMP, CEF, CAZ, CTX, ATM, CIP, NAL, SXT, TET (KAN)
APC6 Enterobacter sp. A2 (99%) AML, AMC, AMP, CEF, CAZ, ATM, CTX, CIP, GEN, KAN, NAL, TET blaTEM-blaSHV
APC11 Pseudomonas putida F1 (99%) AML, AMC, AMP, CEF, CAZ, CTX, ATM, CHL, NAL, SXT blaCTX–M
APC13 Acinetobacter baumannii DSM 30007 (97%) AML, AMP, CEF, CAZ, FEP, ATM (CTX, NAL)
APC14 Pseudomonas mosselii CFML 90-83 (99%) AML, AMC, AMP, CEF, CAZ, CTX, FEP, ATM, TET (NAL)
APC15 Chromobacterium haemolyticum MDA0585 (99%) AML, AMC, AMP, CEF, CAZ, CTX, FEP, IPM, ATM, KAN, NAL
APC19 Escherichia coli O157:H7 Sakai (99%) AML, AMC, AMP, CEF, CAZ, CTX, FEP, ATM, CIP, GEN, KAN, NAL, SXT, TET blaCTX–M intI2
APC20 Pseudomonas mosselii CFML 90-83 (99%) AML, AMC, AMP, CEF, CAZ, CTX, FEP, ATM (NAL)
APC22 Shigella sonnei Ss046 (99%) AML, AMP, CEF, CTX, FEP, ATM, CIP, GEN, KAN, NAL, SXT (AMC) blaCTX–M–2 intI2
APC24B Escherichia fergusonii ATCC 35469 (99%) AML, AMC, AMP, CEF, CAZ, CTX, FEP, ATM, CIP, KAN, NAL, SXT, TET blaCTX–M IntI1
APC28 Klebsiella pneumoniae DSM 30104 (96%) AML, AMC, AMP, CEF, CAZ, CTX, FEP, ATM, CIP, KAN, NAL, SXT, TET (C) blaTEM- blaSHV-blaCTX–M–15 intI1
APC32 Escherichia fergusonii ATCC 35469 (97%) AML, AMP, CEF, CAZ, CTX, FEP, ATM, SXT (AMC, CIP, KAN) blaTEM-blaCTX–M–15
APC33 Shigella sonnei Ss046 (99%) AML, AMC, AMP, CEF, CAZ, CTX, FEP, ATM, CIP, NAL blaCTX–M–15
APC34 Escherichia coli NBRC 102203 (98%) AML, AMC, AMP, CEF, CAZ, CTX, FEP, ATM, CIP, KAN, NAL, SXT, TET blaCTX–M IntI2
APC38 Escherichia fergusonii ATCC 35469 (98%) AML, AMC, AMP, CEF, CTX, FEP, ATM, CIP, GEN, CHL, KAN, NAL, SXT, TET blaCTX–M IntI2
APC39 Acinetobacter nosocomialis RUH2376 (99%) AML, AMC, AMP, CEF, CAZ, CTX, ATM, CIP, KAN, NAL, SXT, TET
APC40A Escherichia fergusonii ATCC 35469 (99%) AML, AMC, AMP, CEF, CAZ, CTX, FEP, ATM, CIP, GEN, CHL, NAL, SXT (KAN) blaCTX–M–14 intI1-intI2
APC42 Acinetobacter baumanii DSM 30007 (99%) AML, AMC, AMP, CEF, CAZ, CTX, FEP, ATM, CIP, KAN, NAL, SXT, TET (CHL)
APC43B Shigella sonnei Ss046 (99%) AML, AMC, AMP, CEF, CAZ, CTX, FEP, ATM, CIP, GEN, KAN, NAL, SXT, TET (CHL) blaCTX–M–15
API2 Klebsiella pneumoniae R-70 (99%) AML, ATM, C, KAN, SXT, TET (AMP, CIP) IntI1
API3 Enterobacter asburiae JCM6051 (94%) AML, AMC, AMP, CEF, CAZ, ATM, CHL, KAN, NAL, TET
API4 Klebsiella pneumoniae 07A044 (99%) AML, AMC, AMP, CEF, ATM, SXT, TET (CTX, NAL) blaSHV
API6 Leclercia adecarboxylata CIP 82.92 (99%) AML, AMC, AMP, CEF, ATM, CHL, KAN, NAL, TET (CTX)
API7 Enterobacter cloacae LMG 2683 (99%) AML, AMC, AMP, CEF (CTX, ATM)
API10 Enterobacter tabaci YIM Hb-3 (99%) AML, AMC, AMP, CEF, ATM, CHL, KAN, NAL (SXT, TET)
API12 Pseudomonas otitidis MCC10330 (99%) AML, AMC, AMP, CEF, ATM, KAN, TET (NAL)
API16 Enterobacter tabaci YIM Hb-3 (100%) AML, AMC, AMP, CEF, ATM, GEN, CHL, NAL, SXT, TET (CTX)
API20 Acinetobacter seifertii LUH 1472 (99%) AML, AMC, AMP, CEF, ATM, CIP, KAN, TET (CAZ, CTX, GEN, CHL)
API24 Phytobacter diazotrophicus Ls8 (98%) AMP, CAZ, CTX, ATM, KAN, NAL (AML, FEP, TET) blaTEM
API29 Klebsiella pneumoniae DSM 30104 (99%) AML, AMP, CEF blaTEM- blaSHV
API34 Klebsiella pneumoniae DSM 30104 (98%) AML, AMP, CEF, CTX, FEP, ATM, CIP, GEN, CHL, NAL, SXT, TET

The BLASTn identity result for each isolate is presented within parentheses after the 16S rRNA affiliation. The abbreviation of antibiotics is as follows: amoxicillin (AML); amoxicillin + clavulanic acid (AMC); ampicillin (AMP); cephalotin (CEF); ceftazidime (CAZ); cefotaxime (CTX); aztreonam (ATM); cefepime (FEP); imipenem (IPM); kanamycin (KAN); gentamicin (GEN); nalidixic acid (NAL); ciprofloxacin (CIP); chloramphenicol (CHL); tetracycline (TET); sulfamethoxazole + trimethoprim (SXT). aIsolates selected for whole genome analysis. The complete analysis of its resistance genotype is presented in main text and in Table 2. bParentheses indicate intermediate susceptibility to the antibiotic.